Library

145 Results

Turning “Oh No” into “No Problem”

Turning “Oh No” into “No Problem”

World Courier | 15-Sep-2014 | Technical / White Paper

With all that’s going on in the world right now it’s vital for us all to have plans in place to deal with the unexpected. We need to be prepared individually,...

Pharmaceutical Development for ADCs

Pharmaceutical Development for ADCs

Baxter BioPharma Solutions | 08-Sep-2014 | Technical / White Paper

Formulation, process, and analytical development for antibody-drug conjugates, or ADCs, is complex.While the development of an aqueous solution formulation...

Analysis & Control of Particles in Biologics

Analysis & Control of Particles in Biologics

SGS Life Science Services | 08-Sep-2014 | Technical / White Paper

A key challenge for companies developing biologics is the control of particles in the product formulation. Regulatory authorities require information on...

Eppendorf

Production of Human Stem Cells in Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 11-Aug-2014 | Application Note

Although successful expansion of mesenchymal stem cells (MSCs) in vitro has been well established, the large clinical-scale production of MSCs remains...

Seamless Scale-Up of Lyophilized Vial Products

Seamless Scale-Up of Lyophilized Vial Products

Patheon Inc | 04-Aug-2014 | Case Study

Manufacturers often face a challenge of scaling-up products while maintaining consistency. Learn how to scale-up such lyophilized products as formulations...

Smarter supply chain strategies for you

Smarter supply chain strategies for you

World Courier | 28-Jul-2014 | Data Sheet

The growing prominence of initiatives like just-in-time supply in the clinical trial market points to two key trends in pharmaceutical development: first,...

Eppendorf

Taking the Strain: Scalable Vaccine Production

Eppendorf for Bioprocess – Solutions that grow with you | 21-Jul-2014 | Case Study

Today, the rapidly expanding demand for vaccine products for viral diseases such as rabies has necessitated the development of more sophisticated production...

DoE Bioprocess Development

DoE Bioprocess Development

Eppendorf for Bioprocess – Solutions that grow with you | 16-Jun-2014 | Data Sheet

Design of Experiments (DoE) is a structured approach to the development and optimization of pharmaceutical processes. Compared with a one-factor-at-a-time...

Boehringer Ingelheim

Setting the Standard for Plasmid DNA Production

Boehringer Ingelheim Biopharmaceuticals GmbH | 06-Jun-2014 | Data Sheet

Boehringer Ingelheim stands out due to global contract manufacturing excellence in plasmid DNA production. It is one of the world’s leading companies for...

Steris

Do you have spores?

A global leader in infection prevention and contamination control | 27-May-2014 | Technical / White Paper

Trending analysis of cleanroom environmental monitoring data sometimes shows the presence of spores. These undesirable microbes must be eradicated quickly...

Industry leading titers of protein in E.coli

Industry leading titers of protein in E.coli

Fujifilm Diosynth Biotechnologies | Recorded the 28-May-2014 | Webinar

The development of large scale E. coli expression systems can be rate limiting in process development.  Fujifilm's pAVEway™ system combines innovative...

LB3 Limited

Ambr™ for cell line and process development

Information not available | 14-Apr-2014 | Case Study

Requirements for rapid development have pushed process runs to a higher throughput in smaller scale. Implementation of a microbioreactor system allows...

Applikon

RAMbio, the high intensity mixer

Applikon Biotechnology | 31-Mar-2014 | Technical / White Paper

The RAMbio® bench top biological mixer utilizes ResonantAcoustic® technology that applies low-frequency, high-intensity acoustic energy to agitate microbial...

Developing a bioformulation stability profile

Developing a bioformulation stability profile

Information not available | 27-Mar-2014 | Technical / White Paper

Rapidly identifying stable biotherapeutic formulations is critical to reducing development costs and determining a biotherapeutic's future success....